Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127408491 | 12740849 | 1 | I | 20160830 | 20160914 | 20160914 | EXP | US-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-123709 | RANBAXY | SELVARAJ SA, CHAIREZ E, WILSON LM, LAZAREV M, BASS EB, HUTFLESS S. USE OF CASE REPORTS AND THE ADVERSE EVENT REPORTING SYSTEM IN SYSTEMATIC REVIEWS: OVERCOMING BARRIERS TO ASSESS THE LINK BETWEEN CROHN^S DISEASE MEDICATIONS AND HEPATOSPLENIC T-CELL LYMPHOMA. SYST REV. 2013;JUL 5;6(7):433-6 | 52.00 | YR | M | Y | 0.00000 | 20160914 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127408491 | 12740849 | 1 | SS | Infliximab | INFLIXIMAB | 1 | Unknown | 0 | |||||||||||
| 127408491 | 12740849 | 2 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | UNK | 0 | ||||||||||
| 127408491 | 12740849 | 3 | PS | PREDNISONE. | PREDNISONE | 1 | Unknown | 89247 | |||||||||||
| 127408491 | 12740849 | 4 | SS | Nortriptyline | NORTRIPTYLINE | 1 | Unknown | 0 | |||||||||||
| 127408491 | 12740849 | 5 | SS | Adalimumab | ADALIMUMAB | 1 | Unknown | 0 | |||||||||||
| 127408491 | 12740849 | 6 | SS | Natalizumab | NATALIZUMAB | 1 | Unknown | 0 | |||||||||||
| 127408491 | 12740849 | 7 | SS | AZATHIOPRINE. | AZATHIOPRINE | 1 | Unknown | UNK | 0 | ||||||||||
| 127408491 | 12740849 | 8 | SS | METHADONE | METHADONE HYDROCHLORIDE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127408491 | 12740849 | 1 | Crohn's disease |
| 127408491 | 12740849 | 2 | Crohn's disease |
| 127408491 | 12740849 | 3 | Crohn's disease |
| 127408491 | 12740849 | 4 | Crohn's disease |
| 127408491 | 12740849 | 5 | Crohn's disease |
| 127408491 | 12740849 | 6 | Crohn's disease |
| 127408491 | 12740849 | 7 | Crohn's disease |
| 127408491 | 12740849 | 8 | Crohn's disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127408491 | 12740849 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127408491 | 12740849 | Hepatosplenic T-cell lymphoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |